Piezo1-mediated cellular apoptosis in breast cancer cells triggered by ultrasound and microbubbles

Nina Qu1, Menglu Bi2, Qingkai Meng3

  • 1Department of Ultrasound Medicine, Yantai Yuhuangding Hospital, Yantai 264000, Shandong, China. ninebaby1006@126.com.

Insights

Ultrasound microbubble (USMB) treatment and Piezo1 agonist (Yoda1) promote breast cancer cell apoptosis by activating ER stress and mitochondrial pathways. The Piezo1 inhibitor (GsMTx4) reversed these effects, highlighting Piezo1

Area of Science:

  • Cell Biology
  • Oncology
  • Biophysics

Background:

  • Piezo1 ion channels are mechanosensitive channels implicated in cellular processes.
  • Dysregulation of apoptosis contributes to breast cancer progression.
  • Targeting Piezo1 presents a potential therapeutic strategy for breast cancer.

Purpose of the Study:

  • To investigate the role of Piezo1 in apoptosis of human breast cancer cells (MCF-7).
  • To evaluate the effects of Piezo1 modulation using Yoda1 (agonist) and GsMTx4 (inhibitor) on apoptosis.
  • To assess the impact of ultrasound microbubble (USMB) treatment on Piezo1-mediated apoptosis.

Main Methods:

  • Western blotting to quantify Piezo1 protein expression in breast cancer cell lines.
  • Flow cytometry to measure apoptosis rates.
  • Assessment of apoptosis-related proteins, ER stress markers, and mitochondrial pathway proteins.
  • Mitochondrial membrane potential and intracellular calcium ion (Ca2+) concentration measurements using fluorescent probes.

Main Results:

  • MCF-7 cells exhibited the highest Piezo1 expression.
  • Yoda1 and USMB significantly increased apoptosis, ER stress, and mitochondrial pathway activation.
  • GsMTx4 inhibited apoptosis and reversed USMB-induced effects.
  • USMB treatment led to decreased mitochondrial membrane potential and increased intracellular Ca2+.

Conclusions:

  • USMB treatment activates ER stress through Piezo1 in breast cancer cells.
  • USMB induces mitochondrial dysfunction and elevates intracellular Ca2+, promoting apoptosis.
  • Modulating Piezo1 activity offers a potential therapeutic avenue for breast cancer treatment.